36th Psychiatric Pharmacotherapy Update • 2024 - University of Texas at Austin College of Pharmacy

2024 Psychiatric Pharmacotherapy Update

The University of Texas at Austin College of Pharmacy

Thursday, Oct. 24 - Friday, Oct. 25, 2024

About

The 2024 Psychiatric Pharmacotherapy Update offers 14+ hours of CPE content for live and on-demand learning. Registration includes Texas State Board of Pharmacy CE requirements, clinical updates, law updates and more. This event will be held Thursday, Oct. 24 - Friday, Oct. 25.

Target Audience

This seminar is intended for pharmacists, psychiatrists, physicians, nurses, physician assistants, psychologists and social workers* who specialize in or have an interest in neuropsychiatric disorders and wish to enhance their awareness and knowledge of the most recent advances impacting contemporary practice.

*Social workers, please see the agenda to identify which sessions (*) have been designated as information that will meet your specific educational needs, and offer social work-specific continuing education credit. Please feel free to register for the entire conference if you wish to participate in the non-accredited sessions for your own professional development.

Attendance Options

Registrants have the option of joining us live in person in Austin, Texas or via live virtual broadcast. In addition to the live sessions, there will be additional on-demand content included with registration. All live presentations will be recorded and available for on-demand viewing throughout the next year. With many ways to participate, you can’t miss out.

For those joining us in person, visit our location page on the Psychiatric Pharmacotherapy Update website for more information.

Registering and Accessing the Content

Psychiatric Pharmacotherapy Update registrants will access all seminar content on this page. Be sure to bookmark this page for accessing session content, live broadcast Zoom feeds and on-demand sessions. You are required to log into your account to access seminar content, so we recommend you keep your login email and password handy.

Register for 2024 Psychiatric Pharmacotherapy Update

NOTE: If you have previously registered for the live event, skip down to Log Back In.
First, you must register for the activity using the GREEN button at the bottom of the page.
- (Note: If you have never claimed CE credit through this UT Austin College of Pharmacy CE site before, you will also be prompted to create a CE profile before you can register for this program).
Once you are registered & logged in, save your email & password for easier access when you return to complete additional sessions.
Click one of the sessions listed below and follow the instructions listed in that module.
If you wish to return to the program later, do so by following the instructions in the orange box below.

Log Back In

Bookmark this page. When you return, click on the "log in" link at the top right. (NOTE: this registration page is the same page you will use during the live event and for on-demand sessions later.)
Enter your email/password at the prompt.
Click one of the sessions listed below and follow the instructions in that module.

Date: Oct 24, 2024 07:00 AM - Oct 25, 2024 04:30 PM

Fee

$595.00

CE Hours

20.25

CE Units

2.025

Registration closes on Jul 01, 2027 01:00 AM

Activity Type

Knowledge

Support/Credits

Additional Event Information

Session content: Look to the tabs below for content. PDF copies of the presentation slides will be added in each session tab closer to the event day.
Zoom links for live broadcast: As we approach the event, Zoom links will be available below. There is one webinar link for each day. The program will broadcast a constant stream that you can leave and return to as you can. You will need to log into Zoom, but you can use a free Zoom account for this broadcast.
- -- Zoom links to come. --
All content will be recorded: All content will be recorded for viewing online after the event – so if you miss a session, no worries. You will be able to see sessions over the next year (please allow 4 to 6 weeks for recordings to appear).
On-demand sessions: You can open the links below to find the on-demand videos embedded in the system. Recordings of the live sessions will be placed in the tabs in the same way.
Evaluations: You will be able to access and complete evaluations at the scheduled time the live session ends. If the speaker is to finish early, just know the evaluation will eventually become live at the originally scheduled time.
CE credit / certificate: Upon completing the online evaluations following each session. For pharmacy, the credit for that session will be automatically uploaded to the NAPB profile you entered in this system. For all other professions, you can download the certificate after completing evaluations via the "View/Print CE Cert" tab at the top of the page.
Thank you: We know you have options on where you get your CE. We greatly appreciate you choosing The University of Texas at Austin College of Pharmacy! Thank you!

Continuing Education Credit

Pharmacy

Continuing Pharmacy Education: The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This two-day activity is approved for 22.0 CEUs (14 contact hours live with 8 on-demand) of continuing education credit. In order to receive 22.00 contact hours of CE credit, the participant must attend/participate in all sessions of the program, and complete the online evaluations for each session.

Medical

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine and The University of Texas at Austin College of Pharmacy. The Joe R. & Teresa Lozano Long San Antonio School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Long School of Medicine designates this live activity for a maximum of 21.00 AMA PRA Category 1 Credits™ in-person or 21.00 online/on-demand. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Social Work / Counseling / APA

The Office of Professional Development at The University of Texas at Austin Steve Hicks School of Social Work is accredited by the Council on Social Work Education, and as such receives automatic approval as a continuing education provider by the Texas Board of Social Work Examiners under Texas Administrative Code, Title 22, Part 34. § 781.511(c). The program represented by this certificate was provided in accordance with the criteria and standards of the Texas State Board of Social Worker Examiners, and has been approved for Social Workers, Licensed Professional Counselors, and Licensed Marriage and Family Therapists. Please note that 1 hour = 1 CEU. Complaints about this program may be made to TSBSWE 333 Guadalupe St, Tower 3, Room 900, Austin, TX 78701 • 512-305-7700 • 800-821-3205. Peer Counselor / Addition Counselor Provider Number: 2050-20

bhec.texas.gov/texas-state-board-of-social-worker-examiners/

Disclosures: Speakers who have disclosed relevant financial relationships:

Mitigation: The University of Texas at Austin College of Pharmacy event planning committees reviewed the relationships and determined there was no connection between presentations and disclosed relationships.

Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.

Questions?

At any time, please email us at UTpharmacyCE@austin.utexas.edu – we monitor this email daily and will be monitoring it all day during the live event.

36th Psychiatric Pharmacotherapy Update • 2024

Thu, Oct 24, 2024

Psychiatric Pharmacotherapy Update 2024 - Day I

Welcome to Day 1 of the 2024 Psychiatric Pharmacotherapy Update

Thursday, October 24, 2024

The 2024 Psychiatric Pharmacotherapy Update is held as both an in-person and live broadcast event.

Know all content will be recorded for on-demand video learning by December.

Please note the icons in the session tabs below.

The "in-person" icon lets you know the session is for in-person attendance at the DoubleTree

The "live broadcast" icon indicates that the session is available on the Zoom webinar

The "on-demand" icon indicates the session contains a video for viewing the content anytime

Please access presentation slides, evaluations, eventually on-demand videos in the tabs below

Please note, the evaluations will become live at the scheduled time the session is to end. If it ends early, please wait for the scheduled time for it to become open.

Date: 10/24/24

Time: 07:00 AM - 05:00 PM

Event Check-in and Breakfast

In-person — Check-in and Breakfast

In-person attendees can pick up their name badge and program in the registration area.

All programs will be held in the DoubleTree Ballroom. The check-in area is just outside the classroom.

Breakfast for in-person attendees will be provided each morning starting at 7:30 a.m.

Date: 10/24/24

Time: 07:30 AM - 08:00 AM

Welcome and Morning Announcements

Welcome and Morning Announcements

Date: 10/24/24

Time: 08:00 AM - 08:15 AM

Psychopharmacology Fact or Myth?

Psychopharmacology Fact or Myth?

Learning Objectives

Assess common misperceptions in psychopharmacology related to treating patients with serious mental illness (SMI).
Evaluate if available evidence supports or disproves common psychopharmacologic treatment myths.
Create evidence-based recommendations using case examples.

About the Speakers

Brendon Hogan, Pharm.D., BCPP

VISN12 CRH Pharmacy Program Manager
Clinical Pharmacy Specialist – Psychiatry
Mental Health and Pain Clinical Pharmacy Practitioners
Certified BFA Instructor

Brendon Hogan obtained his B.A. in Bio-Chemistry from the University of North Texas in 2010 and his Doctorate in Pharmacy from the University of Texas at Austin in 2015. He completed a PGY1 General Pharmacy Residency in 2016 and a PGY2 in Psychiatric Pharmacy Residency in 2017 at the Central Texas Veterans Health Care System (CTVHCS) in Temple, Texas. He then began work in the outpatient mental health clinic (MHC) at CTVHCS doing medication management and using non-traditional treatment modalities such as auricular acupuncture and cranial electrotherapy stimulation. In 2018 he became Residency Program Director (RPD) for the PGY2 Psychiatric Pharmacy program and in 2019 he became a certified trainer for Battlefield Acupuncture (BFA). In December 2019 he was hired as the Clinical Pharmacy Supervisor for the Mental Health and Pain Clinical Pharmacy Practitioners (CPP). In 2024 he became the Pharmacist Program Manager for VISN12 Clinical Resource Hub

Disclosure: Dr. Hogan does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Kristen Neumeister, Pharm.D., BCPP

Clinical Pharmacy Specialist - Psychiatry

Health and Specialty Care System | North Texas State Hospital

Texas Health and Human Services Commission

Please check back later for this speaker's bio.

Disclosure: Dr. Neumeister does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Date: 10/24/24

Time: 08:15 AM - 09:15 AM

CE Hours

1.00

Autism and Psychiatric Disorders

Autism and Psychiatric Disorders

Learning Objectives

Learning Objectives for this session will be available closer to the conference date.

About the Speaker

Young Shin Kim, M.D., Ph.D.

Professor

Department of Psychiatry and Behavioral Sciences

The University of Texas at Austin Dell Medical School

Please check back later for this speaker's bio.

Disclosure: Dr. Kim does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Date: 10/24/24

Time: 09:15 AM - 10:15 AM

CE Hours

1.00

Break

Refreshment Break (15 minutes)

In-person attendees: Join us for a refreshment break.

Virtual attendees: Please enjoy a quick break.

Date: 10/24/24

Time: 10:15 AM - 10:30 AM

Evaluating Psychotropic Medications: Valuable New Agents for Patients vs. Profitable Additions for Companies?

Evaluating Psychotropic Medications: Valuable New Agents for Patients vs. Profitable Additions for Companies?

Learning Objectives

Discuss the obstacles to new medication development.
What is a therapeutic breakthrough and what is a me-too psychotropic medication?
Outline the role that serendipity has played in psychotropic drug development.
Delineate potential innovations psychotropic drug development.

About the Speaker

M. Lynn Crismon, Pharm.D., FCCP, DABCP, BCPP

Dean Emeritus

Behrens Centennial Professor Emeritus of Pharmacy

Professor of Psychiatry and Behavioral Sciences

The University of Texas at Austin College of Pharmacy

M. Lynn Crismon is Dean Emeritus and Behrens Centennial Professor Emeritus of Pharmacy and Professor of Psychiatry & Behavioral Sciences at The University of Texas at Austin. He is board-certified in psychiatric pharmacy, and he is a Diplomate of the American Board of Clinical Pharmacology. His research has focused on strategies to improve the pharmacotherapy and health outcomes of adults and children with severe mental disorders. He is vice chair and founding steering committee member, faculty member, and coach in the REACH Institute’s Patient-Centered Mental Health in Pediatric Primary Care Mini-fellowship. He served as a member of the National Academy of Medicine Committee that developed Taking Action Against Clinician Burnout: A Systems Approach to Professional Well-Being which received the 2021 James A. Hamilton Book Award from the American College of Healthcare Executives. In 2021 he was awarded the ACCP Paul F. Parker Medal for Distinguished Service to the Profession of Pharmacy, and he is the 2024 recipient of the AACP Paul R. Dawson Award for Excellence in Patient Care Research Award.

Disclosure: Dr. Crismon does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Date: 10/24/24

Time: 10:30 AM - 11:30 AM

CE Hours

1.00

Psychedelic Treatment of Mental Illness

Psychedelic Treatment of Mental Illness

Learning Objectives

Identify factors that differentiate psychedelic-assisted therapies from other evidence-based treatment approaches
Discuss psilocybin-assisted psychotherapy evidence base
Discuss MDMA-assisted psychotherapy evidence base
Identify key areas for further development in optimizing and disseminating this novel approach

About the Speaker

Greg Fonzo, Ph.D.
Assistant Professor and Co-Director

Center for Psychedelic Research and Therapy

Department of Psychiatry and Behavioral Sciences

The University of Texas at Austin Dell Medical School

Please check back later for this speaker's bio.

Disclosure: Dr. Fonzo does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Date: 10/24/24

Time: 11:30 AM - 12:45 PM

CE Hours

1.25

Lunch - Optional Continuing Professional Development

Lunch

Optional Continuing Professional Development Discussion

In-person attendees: Join us for lunch.

Virtual attendees: Please enjoy a lunch break.

Optional Continuing Professional Development Discussion

This optional Continuing Professional Development Discussion involves guided reflections about topics and treatment changes based on morning topics. Participants may choose any topic from the conference presentations that are most likely to impact or improve their practice.

Worksheet: For in-person attendees, you can pick up a worksheet at the check-in table, others may use the downloadable document. Use this document for the discussion and reflection of the chosen topic. The worksheet displays areas that have been demonstrated as the major barriers or areas that impact the implementation of new content into practice.

Take notes as you reflect. When you go to complete the evaluations for CE credit, the evaluation will ask you to share what you wrote in the worksheet. (NOTE: simple answers will not result in credit - one must truly reflect on the topic.

Learning Objectives

Discuss the impact of key takeaways of conference topics on practice
Discuss practice implementation planning for conference topics

About this Program:

Literature on continuing education in healthcare has demonstrated a lack of results from learning new knowledge to the actual implementation of new knowledge into practice. The process of implementation includes several steps or barriers to the implementation of new knowledge. These include:

Identifying what changes in practice
Understanding the impact and/or need for other healthcare team members' involvement
Changes or updates to existing guidelines that may create barriers to implementation
Using tools and information from the presentation to help facilitate implementation
Steps of actual implementation - this may include understanding the timing and frequency of actual change

Contemplating and understanding the steps and barriers to implementation have been shown to make a significant difference in the actual implementation of new knowledge into practice. The use of this exercise on key concepts will help ensure the use of new knowledge in practice.

Facilitator: Glen Baumgart, Ph.D. serves as Director of the Center for Continuing Professional Development at The University of Texas at Austin College of Pharmacy. He holds a doctorate in educational psychology and has extensive experience in managing education discussion sessions. Disclosure: Dr. Baumgart has no financial relationship(s) to disclose.

Date: 10/24/24

Time: 12:45 PM - 01:45 PM

CE Hours

0.50

The Role of Ketamine and Esketamine in Practice and the Logistics of Prescribing

The Role of Ketamine and Esketamine in Practice and the Logistics of Prescribing

Learning Objectives

Review the FDA-approved and evidence-supported off-label use of Ketamine and Esketamine for treatment-resistant depression and suicidality.
Identify when it is recommended to implement ketamine/esketamine vs other treatment modalities for treatment-resistant depression and suicidality, including guidelines if they exist.
Discuss potential barriers or warnings to patients and providers with the wide range of ketamine and esketamine options available such as telehealth supervised administration, ED, and other non-psychiatric infusion options

About the Speaker

Brent Turnipseed, M.D.
Medical Director

Roots Behavioral Health

Brent Turnipseed, M.D., is a co-founder and Medical Director of Roots Behavioral Health, a mental health clinic in Austin, Texas. He is board-certified by the American Board of Psychiatry and Neurology and a Fellow of the American Psychiatric Association. In collaboration with Dr. Phil Wolfson and the Ketamine Training Center in San Anselmo, California, Dr. Turnipseed published the first observational cohort of ketamine-assisted psychotherapy outcomes. Additionally, he served as principal investigator for NRX Pharmaceuticals’ phase II trial for NRX-101, an investigational drug for treating bipolar depression. As Roots’ Medical Director, Dr. Turnipseed is leading a novel approach to psychiatric care by utilizing the Brain Health Assessment. This tool helps patients understand contributing factors to their mental illness and how best to address them.

Disclosure: Dr. Turnispeed does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Date: 10/24/24

Time: 01:45 PM - 02:45 PM

CE Hours

1.00

Break

Refreshment Break (15 minutes)

In-person attendees: Join us for a refreshment break.

Virtual attendees: Please enjoy a quick break.

Date: 10/24/24

Time: 02:45 PM - 03:00 PM

Psychotropic Stewardship: Focus on Antipsychotics

Psychotropic Stewardship: Focus on Antipsychotics

Learning Objectives

Define the concepts of Psychotropic Stewardship and how these can be applied to antipsychotic use.
Review the literature supporting the vision of psychotropic stewardship and antipsychotic medications.
Recommend initial steps to implement a pharmacist led psychotropic stewardship program supporting safe antipsychotic use
Measure the effectiveness of a psychotropic stewardship program for antipsychotics

About the Speaker

Robert Haight, Pharm.D., BCPP
Clinical Pharmacist | Forensic Services
Saint Peter Regional Treatment Center (SPRTC)
Minnesota Department of Human Services

Dr. Robert Haight earned a Doctor of Pharmacy from the University of Minnesota, College of Pharmacy in 1998 and completed a residency in Psychopharmacology Research at Regions Hospital, Saint Paul, Minnesota in 1999. Dr. Haight joined the University of Minnesota Medical Center (UMMC) in Minneapolis, Minnesota as a Clinical Pharmacy Specialist in Psychiatry in 2001. In May 2020 he joined the Minnesota Department of Human Services in Forensic Services at the Saint Peter Regional Treatment Center. He also spends 50% of his time working with patients with intellectual and developmental disabilities at the Southern Cities Clinic through Minnesota Department of Human Services, Direct Care and Treatment. Dr. Haight is the SPRTC residency coordinator for the Minnesota Direct Care and Treatment, PGY2 Psychiatric Pharmacy Residency Program. His interests include the use of shared decision-making aids, psychotropic stewardship, and improving transitions of care by utilizing psychiatric pharmacy and medication therapy management teams.

Disclosure: Dr. Haight does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Date: 10/24/24

Time: 03:00 PM - 04:00 PM

CE Hours

1.00

Psychotropic New Drug Update

Psychotropic New Drug Update

Learning Objectives

Describe the pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.
Review pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs that have been released in the past five years.

About the Speaker

Stephen R. Saklad, Pharm.D., BCPP

Clinical Professor (Retired)

The University of Texas at Austin College of Pharmacy

Division of Pharmacotherapy, UT Health San Antonio, Joe R. & Teresa Lozano Long School of Medicine

Pharmacotherapy Education and Research Center

Dr. Saklad is a Clinical Professor at The University of Texas College of Pharmacy and a Pharmacist at San Antonio State Hospital since 1979. He has focused his career on clinical care, teaching, and research to improve the quality of life and function in the serious and persistently mentally ill. He helped to create a clinical research unit at San Antonio State Hospital and developed the first websites for The University of Texas College of Pharmacy and the College of Psychiatric and Neurologic Pharmacists (CPNP). He is the Director of the University of Texas Psychiatric Pharmacy Program in San Antonio, having trained over 70 advanced practice pharmacists in psychiatric pharmacy. Dr. Saklad is a Founding Member of CPNP, served on the CPNP Board of Directors and was the founding senior editor of their peer-reviewed journal, the Mental Health Clinician. He has published articles and presented to many groups around the country on a variety of pharmacy and mental health-related topics. He is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, and other serious mental illnesses, as well as their pharmacokinetics and interactions. He has received several honors, most recently the Judith J. Saklad Memorial Award from CPNP in 2012 and the Teaching Excellence Award from the UT College of Pharmacy in 2013.

Disclosure: Dr. Stephen Saklad has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:

Speakers Bureau: Actavis, Otsuka, Sunovion

Consultant: Janssen, Jazz, Otuska, Teva

Other: Member of Pharmacists Foundation, Business Development Council for San Antonio

Date: 10/24/24

Time: 04:00 PM - 05:00 PM

CE Hours

1.00

Reception

Reception

In-person attendees: Join us for refreshments at our end-of-day reception.

Date: 10/24/24

Time: 05:00 PM - 05:30 PM

Fri, Oct 25, 2024

2024 Psychiatric Pharmacotherapy Update - Day II

Welcome to Day 2 of the 2024 Psychiatric Pharmacotherapy Update

Friday October 25, 2024

The 2024 Psychiatric Pharmacotherapy Update is held as both an in-person and live broadcast event.

Know all content will be recorded for on-demand video learning by December.

Please note the icons in the session tabs below.

The "in-person" icon lets you know the session is for in-person attendance at the DoubleTree

The "live broadcast" icon indicates that the session is available on the Zoom fee

The "on-demand" icon indicates the session contains a video for viewing the content anytime.

Please access presentation slides, evaluations, eventually on-demand videos in the tabs below

Please note, the evaluations will become live at the scheduled time the session is to end. If it ends early, please wait for the scheduled time for it to become open.

Date: 10/25/24

Time: 07:30 AM - 05:00 PM

Check-in and Breakfast

In-person — Check-in and Breakfast

In-person attendees can pick up their name badge and program in the registration area.

All programs will be held in the DoubleTree Ballroom. The check-in area is just outside the classroom.

Breakfast for in-person attendees will be provided each morning starting at 7:30 a.m.

Date: 10/25/24

Time: 07:30 AM - 08:00 AM

Welcome and Morning Announcements

Welcome and Morning Announcements

Date: 10/25/24

Time: 08:00 AM - 08:15 AM

Effectiveness of Non-stimulants vs Stimulants for ADHD in Children and Adults

Effectiveness of Non-stimulants vs Stimulants for ADHD in Children and Adults

Learning Objectives

Review current studies of both stimulants and non stimulant in the treatment of ADHD in both children and adults.
Compare and contrast the efficacy and rate of adverse events in both stimulants and non-stimulants for both stimulants and non-stimulants.
Examine recent "Big Data" studies that address the long term risks and benefits of the pharmacological treatment of ADHD.

About the Speaker

Steven R. Pliszka, M.D.

Professor of Psychiatry

The University of Texas Health San Antonio

Steven R. Pliszka, M.D. is Professor of Psychiatry at the University of Texas Health Science Center at San Antonio. He has been a faculty member at UT Health San Antonio since 1986, joining the Department of Psychiatry after completing his general and child adolescent psychiatry residencies at UTHSCSA. Throughout his career he has been involved in a wide range of administrative, research, clinical and educational activities. He has as Chief of the Division of Child and Adolescent Psychiatry from 1995-2015 and Chair of the Department of Psychiatry & Behavioral Sciences from 2015-2023. His research has focused on Attention Deficit Hyperactivity Disorder (ADHD) and related disorders. He has been involved with clinical trials of the most medications used for ADHD. Dr. Pliszka is the author of “Neuroscience for the Mental Health Clinician, 2nd ed.” and “Treating ADHD and Comorbid Disorders (Guilford Press). He has been very active in the American Academy of Child and Adolescent Psychiatry, authoring the academy’s practice parameters for the diagnosis and treatment of ADHD in 2007. He currently is the Medical Director for the San Antonio branch of Texas Child Health Access Through Telemedicine (TCHATT), a state-wide program for expanding mental health treatment in schools. Dr. Pliszka serves as the attending psychiatrist for two residential facilities for children with severe behavioral and emotional disorders.

Disclosure: Dr. Pliszka does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Date: 10/25/24

Time: 08:15 AM - 09:15 AM

CE Hours

1.00

Dopamine Supersensitivity

Dopamine Supersensitivity

Learning Objectives

Review prevalence and clinical features for dopamine supersensitivity psychosis
Identify risk factors of aripiprazole-related psychotic exacerbation
Discuss a case involving suspected dopamine supersensitivity psychosis

About the Speaker

Lisa M. Mican, Pharm.D., BCPP
Director of Pharmacy
Clinical Coordinator
Austin State Hospital

Lisa M. Mican, Pharm.D., BCPP is the Director of Pharmacy for the Austin State Hospital. She obtained her Pharm.D. from the University of Texas in 2000 and completed her psychiatric residency training at the Audie L. Murphy VA Hospital in San Antonio. Dr. Mican is a Board-Certified Psychiatric Pharmacist and has been practicing at the Austin State Hospital since 2002. She coordinates clinical pharmacy services for the facility including decentralized team-based care and currently serves on the child and adolescent team, with other clinical pharmacists serving on the geriatrics and adult acute care teams. She coordinates the facility pharmacy consultation service and recently implemented a new medication education and assessment consultation service for 46C clients. She mentors and precepts pharmacist trainees from UT Austin and Texas A&M Kingsville Colleges of Pharmacy. She received the Texas Health and Human Services Patient Care Hospital Hero Award in 2018. Dr. Mican leads quality improvement initiatives for the department and this past year the pharmacy department, in coordination with nursing services, received a Texas Health and Human Services Quality Improvement Award for the Vaccination Program Process Improvement. Recent presentations include “Clinical Pharmacy Services in an Inpatient Psychiatric Hospital” at the European Society of Medicine Congress Vienna, Austria and continuing education programs on Benzodiazepine Deprescribing and Use of Long-Acting Antipsychotic Injectable medications for Texas Health and Human Services. She served as an exam item writer for the Board of Psychiatric Specialties certification exam and manuscript peer reviewer for pharmacy and psychiatry journals.

Disclosure: Dr. Mican does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Date: 10/25/24

Time: 09:15 AM - 10:15 AM

CE Hours

1.00

Rapid Fire: Mental Health Treatment Updates

Rapid Fire: Mental Health Treatment Updates

This session consists of four 15-minute sessions. All speakers will be available for a Q&A panel at the end of the presentations.

Learning Objectives

Schizophrenia Update: Discussion of New Treatments – Dr. Troy A. Moore

• Discuss new schizophrenia treatments and pipeline medications

Bipolar Disorder Update – Dr. Rania Kattura

• Discuss various types and uses of the most common eye drops

Alzheimer's Update: Recent Discoveries and Treatments – Dr. Sudha Seshadri

• Discuss recent updates in the treatment of Alzheimer's.

Insomnia Update: Review of Melatonin – Dr. Samantha Catazano

• Discuss the use and effectiveness of melatonin and other common agents in the treatment of insomnia

About the Speakers

Troy A. Moore, Pharm.D., M.S. Pharm., BCPP

Director, ASHP Accredited PGY-1 Pharmacy Residency Program

Clinical Pharmacy Specialist, Mental Health

Rocky Mountain Regional VA Medical Center

Troy A. Moore received his PharmD from the University of New Mexico College of Pharmacy in 2003. He subsequently attended the University of Texas at Austin College, receiving his Master of Science in Pharmacy in 2005 while completing a 2-year Psychiatric Pharmacy at the San Antonio State Hospital and the South Texas Veterans Health Care System (STVHCS). He joined the University of Texas Health Science Center at San Antonio Department of Psychiatry, Division of Schizophrenia and Related Disorders in 2005 and became Assistant Professor in 2007. He joined the STVHCS as Clinical Pharmacy Specialist in Psychiatry in 2010 where he served the Substance Abuse and Domiciliary Programs. He accepted an appointment as the PGY-1 Pharmacy Residency Program Director and Clinical Pharmacy Specialist in Mental Health at the VA Eastern Colorado Health Care System (ECHCS) in Aurora, CO in December 2018. He is currently a member of the ECHCS PTSD Clinical Team (PCT) program. He has also been on the planning committee for UT Psych Update since 2007

Disclosure: Dr. Moore has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose: Advisory Board for Aklermes

Rania Kattura, Pharm.D., M.S.Phr., BCPP
Clinical Psychiatric Pharmacist
Austin State Hospital

Dr. Rania Kattura received her Pharm.D. degree at The University of Texas at Austin College of Pharmacy. She completed a PGY2 in Residency Psychiatric Pharmacy in combination with a Master of Science in Pharmacy at The University of Texas at Austin and its affiliated institutions (Austin State Hospital, Seton Shoal Creek, Temple VA and City of Austin Community Clinics). She is board certified in psychiatric pharmacy. Currently, Dr. Kattura is a Clinical Pharmacist at the Austin State Hospital. As a clinical pharmacist, she participates in direct patient care as a member of a multidisciplinary treatment team, provides weekly medication education groups and completes psychopharmacology consults when requested by the physicians at the hospital. The patient population she works with suffers from a variety of psychiatric disorders such as depression, schizophrenia and bipolar disorder. In addition to her patient care responsibilities, Dr. Kattura staffs in the ASH pharmacy and precepts Pharm.D. students on rotation. Dr. Kattura ensures to attend the UT Psych Update annually and has been a member of its planning committee for many years.

Disclosure: Dr. Kattura does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Sudha Seshadri, M.D.

Biggs Institute for Alzheimer’s & Neurodegenerative Disease

Please check back later for this speaker's bio.

Disclosure: Dr. Seshadri does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Samantha Catanzano, Pharm.D., BCPP
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy

After graduating with her Pharm.D. degree from the University of Texas at Austin, Dr. Catanzano completed a pharmacy practice residency followed by a psychiatric pharmacy practice residency at Seton Healthcare Family and The University of Texas at Austin College of Pharmacy. Following her residency training, she gained experience as a clinical and staff pharmacist at the Austin State Hospital. Currently, she serves as a Clinical Assistant Professor for The University of Texas at Austin College of Pharmacy. She also provides academic lectures to first- and second-year psychiatry residents and addiction medicine fellows through Dell Medical School’s Department of Psychiatry. In addition to her academic appointment, she is a Psychiatric Pharmacist at UT Health Austin within the Integrated Behavioral Health Department where she serves the Primary Care, Musculoskeletal, Post-COVID-19 Program, and Multiple Sclerosis clinics. In this role, she functions as part of a multidisciplinary team to address complex pharmacology and mental health needs in the community setting. Additionally, she is a certified Mental Health First Aid instructor and is an active leader within the American Association of Psychiatric Pharmacists (AAPP).

Disclosure: Dr. Catanzano does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Date: 10/25/24

Time: 10:15 AM - 10:30 AM

CE Hours

1.50

Lunch - Optional Continuing Professional Development

Lunch

Optional Continuing Professional Development Discussion

In-person attendees: Join us for lunch.

Virtual attendees: Please enjoy a lunch break.

Optional Continuing Professional Development Discussion

Worksheet: For in-person attendees, you can pick up a worksheet at the check-in table, others may use the downloadable document. Use this document for the discussion and reflection on the chosen topic. The worksheet displays areas that have been demonstrated as the major barriers or areas that impact the implementation of new content into practice.

Learning Objectives

Discuss the impact of key takeaways of conference topics on practice
Discuss practice implementation planning for conference topics

About this Program:

Identifying what changes in practice
Understanding the impact and/or need for other healthcare team members' involvement
Changes or updates to existing guidelines that may create barriers to implementation
Using tools and information from the presentation to help facilitate implementation
Steps of actual implementation - this may include understanding the timing and frequency of actual change

Date: 10/25/24

Time: 12:00 PM - 01:00 PM

CE Hours

0.50

Long-Acting Injectable Antipsychotic Update

Long-Acting Injectable Antipsychotic Update

Learning Objectives

Discuss information resources for the newly released LAIs and how they differ.
Describe accessible location for LAI administration and pharmacists need to have appropriate locations for administration and knowledge of to prepare and administer each of the different LAIs.
Improve communication with the healthcare team members, patients, and families/caregivers to improve adherence and handle the expected requests to return to oral medication.

About the Speaker

Stephen R. Saklad, Pharm.D., BCPP

Clinical Professor (Retired)

The University of Texas at Austin College of Pharmacy

Division of Pharmacotherapy, UT Health San Antonio, Joe R. & Teresa Lozano Long School of Medicine

Pharmacotherapy Education and Research Center

Disclosure: Dr. Stephen Saklad has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:

Speakers Bureau: Actavis, Otsuka, Sunovion

Consultant: Janssen, Jazz, Otuska, Teva

Other: Member of Pharmacists Foundation, Business Development Council for San Antonio

Date: 10/25/24

Time: 01:00 PM - 02:00 PM

CE Hours

1.00

Refreshment Break

Refreshment Break (15 minutes)

In-person attendees: Join us for a refreshment break.

Virtual attendees: Please enjoy a quick break.

Date: 10/25/24

Time: 02:00 PM - 02:15 PM

Pharmacotherapy of Disruptive Behavior Disorders in Youth

Pharmacotherapy of Disruptive Behavior Disorders in Youth

Learning Objectives

Discuss the mental disorders associated with aggression in youth
Indicate the appropriate assessment of aggression in youth
Outline pharmacotherapy options for the treatment of aggression in youth

About the Speaker

M. Lynn Crismon, Pharm.D., FCCP, DABCP, BCPP

Dean Emeritus

Behrens Centennial Professor Emeritus of Pharmacy

Professor of Psychiatry and Behavioral Sciences

The University of Texas at Austin College of Pharmacy

Disclosure: Dr. Crismon does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Date: 10/25/24

Time: 04:00 PM - 05:00 PM

CE Hours

1.00

TEACH OUD: Texans Expanding Access to Compassionate Healthcare for Opioid Use Disorder

TEACH OUD: Texans Expanding Access to Compassionate Healthcare for Opioid Use Disorder

Learning Objectives

Recognize the individual and societal impacts of opioid use and opioid use disorder (OUD) with an emphasis on Texas.
Discuss evidence-based practices and effective treatment planning
Demonstrate person-centered, ethical approaches to patient care and patient communication.
Identify opportunities to implement evidence-based practices in the primary care setting.

About the Speaker

Daniel Sledge, B.A., L.P.

Academic Detailer

PhARM Program

The University of Texas at Austin College of Pharmacy

Please check back later for this speaker's bio.

Disclosure: Daniel Sledge does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Date: 10/25/24

Time: 03:15 PM - 04:15 PM

CE Hours

1.00

2024 Psychiatric Pharmacotherapy Update - Adjourns

Thank you for attending the 2024 Psychiatric Pharmacotherapy Update!

Date: 10/25/24

Time: 04:15 PM - 05:00 PM

OVERALL EVALUATION - please complete

Please help us evaluate this program. Thank you for your time

Date: 10/25/24

Time: 04:00 PM - 05:00 PM

On-Demand: Assessment and Management of Anxiety Disorders Among Older Adults

On-Demand: Assessment and Management of Anxiety Disorders Among Older Adults

Learning Objectives

Discuss the epidemiology of anxiety disorders among older adults
Describe the assessment of anxiety disorders among older adults
Enumerate the evidence-based treatments for anxiety disorders among older adults

About the Speaker

Rajesh Tampi,.D., M.S., DFAPA, DFAAGP

Professor and Chairman

Department of Psychiatry Creighton University

Dr. Tampi is the Professor (Tenured) and Chairman of the Department of Psychiatry, Inaugural Bhatia Family Endowed Chair in Psychiatry at Creighton University School of Medicine and Catholic Health Initiatives (CHI) Health Behavioral Health Services in Omaha, Nebraska. Dr. Tampi is also a Professor (Adjunct) of Psychiatry at Yale School of Medicine in New Haven, Connecticut. Dr. Tampi is the inaugural Historian of the American Association for Geriatric Psychiatry (AAGP). He is also a Past President of the AAGP. Dr. Tampi is a recipient of the Geriatric Academic Career Award (GACA) instituted by the Department of Health and Human Services (DHHS). He was a recipient of the AAGP’s ‘Clinician of the Year Award’ in 2013. Dr. Tampi also received the AAGP’s ‘Recognition and Appreciation’ Certificate in 2018. In 2019, he received the AAGP’s ‘Educator of the Year Award’. Dr. Tampi received the ‘2019 Outstanding Academician of the Year Award’ given by the Indo-American Psychiatric Association (IAPA). He is the recipient of the 2021 ‘Jack Weinberg Award’ for Geriatric Psychiatry given by the APA. Dr. Tampi has been honored with the 2022 ‘George Tarjan Award’ by the APA. Dr. Tampi has over 200 publications on various topics in Psychiatry and Geriatric Psychiatry. In addition, he is the Editor of 10 books in Psychiatry and Geriatric Psychiatry. Dr. Tampi serves as an Editor-in-Chief of the World Journal of Psychiatry. He is also a Triage Editor for International Psychogeriatrics, an Associate Editor for Drugs in Context (Psychiatry), an Associate Editor for the Aging Psychiatry Section of Frontiers in Psychiatry and the Section Editor of Geriatric Psychiatry for Psychiatric Times.

Disclosure: Dr. Rajesh Tampi does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

On-Demand: Understanding Drug Interactions in Mental Health

Understanding Drug Interactions in Mental Health

Learning Objectives

Describe the three major mechanisms of drug-drug interactions
Explain why understanding drug-drug interactions and clearly explaining them to patients are critical for the safe use of medications
List three clinically important drug-drug interactions that impact medications you see in your routine practice

About the Speaker

Stephen Saklad, Pharm.D., BCPP

Director, Psychiatric Pharmacy Program, Clinical Professor

The University of Texas at Austin College of Pharmacy

Disclosure: Dr. Stephen Saklad has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:

Speakers Bureau: Actavis, Otsuka, Sunovion

Consultant: Janssen, Jazz, Otuska, Teva

Other: Member of Pharmacists Foundation, Business Development Council for San Antonio

Activity Number

0067-0000-24-119-H01-P/T

Release Date: Sep 8, 2024

Credit Expiration Date: Sep 1, 2027

CE Hours

1.00

On-Demand: Evidence-Based Practice for the Busy Clinician: Finding & Utilizing Guidelines to Optimize Patient Care

Evidence-Based Practice for the Busy Clinician: Finding & Utilizing Guidelines to Optimize Patient Care

Learning Objectives

Identify strategies to locate & navigate patient care guidelines.
Review recent guideline updates for common chronic conditions.
Create a personal development plan for staying up to date with guidelines in practice.

About the Speaker

Kristin Janzen, Pharm.D., BCPS

Clinical Assistant Professor

The University of Texas at Austin College of Pharmacy

Kristin Janzen is a Clinical Assistant Professor at the University of Texas at Austin College of Pharmacy. After graduating from UT College of Pharmacy, she completed a combined PGY1 & 2 Pharmacotherapy residency at Butler University and Indiana University Health in Indianapolis, IN. She currently practices at Dell Seton Medical Center at the University of Texas in Internal Medicine, where she precepts fourth-year PharmD students and pharmacy residents on academic internal medicine rotations. She teaches throughout the didactic curriculum at the UT College of Pharmacy, focusing on pharmacotherapeutics, clinical pharmacokinetics, and application-based pharmacy practice labs. She has been recognized for both didactic and experiential teaching and has been awarded the UT Austin College of Pharmacy Educator of the Year, the Austin-Temple-Waco Region Preceptor of the Year, and Wm. Arlyn Koesel Preceptor of the Year Awards. She has also been recognized by the UT Center of Health Interprofessional Practice and Education (IPE) as a Health IPE Fellow. Her research and teaching interests focus on student preparedness for residency, interprofessional education, and core medicine disease states, such as pulmonology, cardiology, and diabetes.

Disclosure: Dr. Janzen does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Activity Number

0067-0000-24-093-L05-P/T

Release Date: Sep 7, 2024

Credit Expiration Date: Sep 6, 2027

CE Hours

1.00

On-Demand: Focus on Medication Safety: Review of Real-Life Case Based Approaches

Focus on Medication Safety: Review of Real-Life Case Based Approaches

Learning Objectives

Identify Institute for Safe Medication Practices (ISMP) Targeted Medication Safety Best Practices for Hospitals
Understand operational considerations related to ISMP Targeted Medication Safety Best Practices implementation in the hospital setting
Evaluate the impact to patient safety of ISMP-targeted medication Safety Best Practices adoption

About the Speakers

Justin Hooper, Pharm.D., BCPS - Moderator

Director, Corporate Clinical Pharmacy
Clinical Excellence Division, CHRISTUS Health

Dr. Justin Hooper graduated from the University of Texas at Austin College of Pharmacy with a Doctor of Pharmacy degree, and later completed a two-year specialty residency in pharmacotherapy with Texas Tech University Health Sciences Center at the Dallas VA Medical Center. After serving on faculty with Texas Tech University School of Pharmacy, Justin returned to his hometown of Tyler to practice pharmacy at CHRISTUS Trinity Mother Frances Health System. While at Trinity Mother Frances, he served in various capacities from staff pharmacist to director of pharmacy. Justin is now Director of Corporate Clinical Pharmacy for CHRISTUS Health, where he provides clinical pharmacy guidance and support for over 300 pharmacists across the CHRISTUS organization from New Mexico to Louisiana. His professional interests include teaching, pharmacy management and quality improvement, and clinical pharmacy informatics. Justin precepts a non-patient care P4 elective rotation and has served as a pharmacy mentor to numerous students and residents for the past ten years. Justin and his wife, Kate, live in Tyler, TX, with their four sons, and are excited to have their oldest son on the UT campus this fall.

Disclosure: Dr. Hooper does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Panel

Tina Collins, Pharm.D.
Director, Corporate Medication Safety
Clinical Excellence Division
CHRISTUS® Health

Tina M. Collins, Pharm.D., is the Corporate Director of Medication Safety, Division of Clinical Excellence, at CHRISTUS Health. She has over 18 years of experience in healthcare and graduated from the University of Louisiana at Monroe (ULM) College of Pharmacy in 2005. She has worn many hats inside the Pharmacy department (NICU Pharmacist, Supervisor, Medication Safety Pharmacist) and beyond (Patient Safety Officer). She is responsible for coaching, guiding, leading, and mentoring Pharmacy leaders to optimize patient care delivery, medication safety, and pharmacy practice.

Disclosure: Dr. Collins does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Rukhsar Banu, Pharm.D.

Medication Safety Officer
Department of Pharmacotherapy and Pharmacy Services
University Health

I am Rukhsar Banu, a dedicated pharmacist passionate about Medication Safety. My journey started in India and continued in the United States, where I honed my skills and knowledge in pharmacy. With 17 years of diverse experience in roles such as pharmacy technician, inventory specialist, intern, and pharmacist, I have consistently contributed to projects focused on medication safety. For example, I reviewed medication errors, supported process improvement, established policies, procedures, and protocols for safe medication use, and implemented the Institute for Safe Medication Practices Best Practices. I firmly believe in the power of simplicity to drive positive outcomes. This belief has guided my commitment to excellence and innovation in every project I undertake. My work has not only contributed to my personal and professional growth but has also made a positive impact on our institution. When I'm not working, I enjoy spending quality time with my family, reading, and exploring new destinations. These activities fuel my creativity and contribute to a balanced life, which enhances my professional endeavors. Looking forward, I am excited to embrace new challenges and opportunities in the realm of medication safety. I am eager to collaborate with like-minded professionals and contribute to impactful projects that genuinely make a difference.

Disclosure: Dr. Banu does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Edward Vaughn, Pharm.D., BCPS

Director of Pharmacy, Pharmacy Department
St. David’s Round Rock Medical Center

Edward Vaughn, Pharm.D., BCPS, is the Director of Pharmacy at St. David’s Round Rock Medical Center located in Round Rock Texas. Dr. Vaughn received his Pharm.D. degree from The Texas A&M University College of Pharmacy in Kingsville, Texas. He completed a Pharmacy Practice Residency at Baylor University Medical Center in Dallas, Texas. He has also served in numerous roles including Inpatient Clinical Pharmacist, Operations Pharmacy Manager, Clinical Pharmacy Manager and Director of Pharmacy.

Disclosure: Dr. Vaughn does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Ali-Reza Shah-Mohammadi, Pharm.D., M.S., FISMP, CMQ

Medication Safety Consultant

Patient Safety

The University of Texas MD Anderson Cancer Center

Ali-Reza Shah-Mohammadi, PharmD, MS, FISMP, CMQ, received his Bachelor of Sciences degree inBiochemistry and Biology along with a Bachelor of Arts degree in Chemistry from The University of Texas at Austin. Dr. Shah-Mohammadi attended the University of Houston College of Pharmacy (UHCOP) where he received his Doctor of Pharmacy degree in 2010. Afterwards, he completed a 2-year combined MS/Residency in Health-System Pharmacy Administration at the Harris Health System (formerly Harris County Hospital District) and UHCOP in 2012. He continued his training with a fellowship focusing on safe medication management at the Institute for Safe Medication Practices (ISMP) located in Horsham, PA. Currently, he is a Medication Safety Consultant at The University of Texas MD Anderson Cancer Center in Houston, TX. In his current position, he works alongside a multidisciplinary team conducting root causes analyses; developing and leading implementation of error prevention strategies; ensuring compliance with state and federal regulatory and legal requirements relating to medication safety; building a culture of safety; influencing practice change through collaboration with other disciplines; and developing effective methods for spreading best practices throughout the organization. In addition to the responsibilities above, Dr. Shah-Mohammadi precepts both student pharmacists and pharmacy residents. He has served in different capacities as a member of the Gulf Coast Society of Health-System Pharmacists (GCSHP), the Texas Society of Health-System Pharmacists (TSHP), and the American Society of Health-System Pharmacists (ASHP). He was a past board member and Director for the GCSHP and served as a co-chair within the Texas Medical Center Residency Council. He currently serves as a member of the Board of Alumni for The Houston Program.

Disclosure: Dr. Shah-Mohammadi does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Activity Number

0067-0000-24-112-H01-P/T

Release Date: Jun 22, 2023

Credit Expiration Date: Jun 22, 2027

CE Hours

1.00

On-Demand: Enhancing Pediatric Medication Management in In-Patient Settings

Enhancing Pediatric Medication Management in In-Patient Settings

Learning Objectives

Apply evidence-based dosing guidelines for pediatric patients.
Analyze and mitigate safety risks in pediatric medication management.
Execute safe medication administration protocols for complex care pediatric patients.
Adapt communication strategies for pediatric patients and families, considering diverse needs.

About the Speakers

Sarah Kubes, Pharm.D., BCPPS
Clinical Assistant Professor of Pharmacotherapy
The University of Texas at Austin College of Pharmacy

Dr. Kubes was born and raised in Houston, Texas. She graduated from Texas A&M University in 2006 with a BS in Biomedical Sciences, then attended the University of Houston College of Pharmacy and graduated in 2011. Dr. Kubes continued her post-graduate education as a PGY resident at Memorial Hermann Hospital in the Houston Medical Center and then a PGY2 pediatrics residency at Children’s Memorial Hermann Hospital. Following residency, she accepted a position as a Pediatric Critical Care Clinical Specialist at Cincinnati Children’s Hospital. In 2014, she re-located to San Antonio and took on the role of the Pediatric Infectious Diseases and Antimicrobial Stewardship Pharmacist at The Children’s Hospital of San Antonio. Dr. Kubes joined the UT group in 2018 as a Clinical Assistant Professor in the Pharmacotherapy Division of the College of Pharmacy at The University of Texas at Austin, as well as an Adjoint Assistant Professor in the School of Medicine and The Department of Pediatrics at the University of Texas Health Science Center at San Antonio. In addition to her teaching and research responsibilities within the college, Dr. Kubes is also responsible for clinical pharmacy services and caring for pediatric patients within the University Health System in San Antonio. Dr. Kubes also sits on the CTSHP board as a senior board member, has been appointed by the Texas Attorney General’s office and the Texas Health and Human Services commission as a Texas Medicaid Drug Utilization Review Board Member, serves as the Chair for the UT affiliated Residency Programs and vice chair for the general pediatrics special interest group for the Pediatric Pharmacy Association national organization. Her primary areas of research include quality improvement in pediatrics, cystic fibrosis and infectious diseases. Her clinical interests include pediatrics, infectious diseases and maternal health. In her spare time she is a mom to 3 children, an avid gardener, baker, reader and chicken/turkey/pheasant/duck/quail/bunny/piggy tender.

Disclosure: Dr. Kubes does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Jenna Summerlin, Pharm.D.
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy

Dr. Jenna Summerlin received her Doctor of Pharmacy degree from Union University College of. Pharmacy in Jackson, Tennessee in 2020. She completed a PGY-1 Pharmacy Residency at Methodist University Hospital in Memphis, Tennessee, followed by a PGY-2 Pediatric Pharmacy Residency at Johns Hopkins All Children's Hospital in St. Petersburg, Florida. In July 2022, she joined the faculty at The University of Texas at Austin College of Pharmacy as a Clinical Assistant Professor in the Division of Pharmacy Practice. Dr. Summerlin is a board-certified pediatric pharmacist and maintains a clinical practice site at Dell Children’s Medical Center in pediatric internal medicine where she serves as a clinical pharmacy specialist and precepts residents and fourth-year Pharm.D. students. At the college, she provides didactic lectures, lab facilitation, and structured mentoring throughout the Pharm.D. curriculum.

Disclosure: Dr. Summerlin does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Activity Number

0067-0000-24-102-H01-P/T

Release Date: Jun 21, 2023

Credit Expiration Date: Jun 20, 2027

CE Hours

1.00

On- Demand: Human Trafficking Prevention: Identifying and Responding to Victims of Human Trafficking for Pharmacists & Pharmacy Technicians

Human Trafficking Prevention: Identifying and Responding to Victims of Human Trafficking for Pharmacists & Pharmacy Technicians

Learning Objectives

Describe different types of human trafficking and their local, statewide and international prevalence.
Identify potential signs of human trafficking in victims who present for care in a medical setting.
Discuss the immediate healthcare needs of identified victims and develop ability for trauma-informed response.
Describe available resources for victims’ service and aftercare.

About the Speaker

Kerri Taylor, M.S., ccc-slp
Executive Director at Unbound Houston

Kerri Taylor is the Executive Director of Unbound Now Houston, the local chapter of Unbound Now, an international anti-human trafficking organization which focuses on domestic minor sex trafficking with specific emphasis on prevention efforts with at-risk youth. Unbound works to activate the community to fight human trafficking and is dedicated to public awareness, prevention education, professional training, and survivor advocacy.

Kerri serves on the board of the Brazoria County United Front Coalition to Fight Human Trafficking. In addition to being a member of the Child Sex Trafficking Advisory Council of Harris County, she works closely with the No Trafficking Zone, which was established in 2020, and with NRG stadium. Unbound Now Houston’s advocates are onsite at every Texans home footbal game, providing services for identified victims. In addition, she serves alongside other advocates in Galveston and Brazoria County as a coordinated response protocol for identified victims of human trafficking is developed.

Disclosure: Kerri Taylor does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Activity Number

0067-0000-24-121-L05-P/T

Release Date: Sep 8, 2024

Credit Expiration Date: Sep 7, 2027

CE Hours

1.50

Exhibitor - Teva

Exhibitor - Teva

Exhibitor - Boehringer Ingelheim Virtual Booth

Exhibitor - Boehringer Ingelheim Virtual Booth

Thank you for taking the time to learn more about our treatment options.

At Boehringer Ingelheim Mental Health, we are evolving mental health to enable people to thrive.

We link behavior to the underlying neurobiology to develop targeted therapies that can ease the burden of these conditions, not just the symptoms.

By combining traditional treatments with new and innovative approaches and technologies, we will enable those with mental health conditions such as Schizophrenia or Depression to create more meaningful connections to their lives, loved ones and society.

Boehringer Ingelheim has a rich pipeline in all phases of development.

Visit our websites:

Connecting Psychiatry

BIPI Medicine

SC-US-77636 (9/24)

Exhibitor - UT Medical Branch (UTMB)

Exhibitor - UT Medical Branch (UTMB)

Exhibitor - Intracellular Therapies

Exhibitor - Intracellular Therapies

https://www.intracellulartherapies.com/

Exhibitor

Exhibitor

Exhibitor spots are available for the 2024 Psychiatric Pharmacotherapy Update!

If you or someone you know is interested in being an exhibitor, visit our exhibitor website or email mariana.medina@austin.utexas.edu for more information.

Exhibitor

Exhibitor

Exhibitor spots are available for the 2024 Psychiatric Pharmacotherapy Update!

If you or someone you know is interested in being an exhibitor, visit our exhibitor website or email mariana.medina@austin.utexas.edu for more information.

Exhibitor

Exhibitor

Exhibitor spots are available for the 2024 Psychiatric Pharmacotherapy Update!

If you or someone you know is interested in being an exhibitor, visit our exhibitor website or email mariana.medina@austin.utexas.edu for more information.